Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma.

Elia AR, Caputo S, Bellone M.

Front Immunol. 2018 Jul 31;9:1786. doi: 10.3389/fimmu.2018.01786. eCollection 2018. Review.

2.

Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effect.

Circosta P, Vitaggio K, Elia AR, Todorovic M, Sangiolo D, Carnevale-Schianca F, Vallario A, Geuna M, Aglietta M, Cignetti A.

Immunotherapy. 2018 Jul;10(9):753-767. doi: 10.2217/imt-2017-0139.

PMID:
30008257
3.

Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.

Circosta P, Elia AR, Landra I, Machiorlatti R, Todaro M, Aliberti S, Brusa D, Deaglio S, Chiaretti S, Bruna R, Gottardi D, Massaia M, Giacomo FD, Guarini AR, Foà R, Kyriakides PW, Bareja R, Elemento O, Chichili GR, Monteleone E, Moore PA, Johnson S, Bonvini E, Cignetti A, Inghirami G.

Oncoimmunology. 2018 Feb 8;7(4):e1341032. doi: 10.1080/2162402X.2017.1341032. eCollection 2018.

PMID:
29632712
4.

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.

Elia AR, Grioni M, Basso V, Curnis F, Freschi M, Corti A, Mondino A, Bellone M.

Clin Cancer Res. 2018 May 1;24(9):2171-2181. doi: 10.1158/1078-0432.CCR-17-2210. Epub 2018 Feb 28.

PMID:
29490991
5.

Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer.

Bellone M, Elia AR.

Cytokine Growth Factor Rev. 2017 Aug;36:17-24. doi: 10.1016/j.cytogfr.2017.06.002. Epub 2017 Jun 2. Review.

PMID:
28606732
6.

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors.

Manzo T, Sturmheit T, Basso V, Petrozziello E, Hess Michelini R, Riba M, Freschi M, Elia AR, Grioni M, Curnis F, Protti MP, Schumacher TN, Debets R, Swartz MA, Corti A, Bellone M, Mondino A.

Cancer Res. 2017 Feb 1;77(3):658-671. doi: 10.1158/0008-5472.CAN-16-0725. Epub 2016 Nov 21.

7.

miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.

Orso F, Quirico L, Virga F, Penna E, Dettori D, Cimino D, Coppo R, Grassi E, Elia AR, Brusa D, Deaglio S, Brizzi MF, Stadler MB, Provero P, Caselle M, Taverna D.

Cancer Res. 2016 Sep 1;76(17):5151-62. doi: 10.1158/0008-5472.CAN-15-1322. Epub 2016 Jun 21.

8.

A Communicative Analysis of a Sexual Health Screening Intervention Conducted in a Low-income Housing Complex.

Scott ME, Elia AR, Golden AG.

J Appl Commun Res. 2015 Oct 1;43(4):450-467. Epub 2015 Sep 2.

9.

Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition.

Elia AR, Circosta P, Sangiolo D, Bonini C, Gammaitoni L, Mastaglio S, Genovese P, Geuna M, Avolio F, Inghirami G, Tarella C, Cignetti A.

Hum Gene Ther. 2015 Apr;26(4):220-31. doi: 10.1089/hum.2014.112. Epub 2015 Apr 13.

PMID:
25758764
10.

The molecular and functional characterization of clonally expanded CD8+ TCR BV T cells in eosinophilic granulomatosis with polyangiitis (EGPA).

Boita M, Guida G, Circosta P, Elia AR, Stella S, Heffler E, Badiu I, Martorana D, Mariani S, Rolla G, Cignetti A.

Clin Immunol. 2014 May-Jun;152(1-2):152-63. doi: 10.1016/j.clim.2014.03.001. Epub 2014 Mar 13.

PMID:
24632064
11.

miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.

Pinatel EM, Orso F, Penna E, Cimino D, Elia AR, Circosta P, Dentelli P, Brizzi MF, Provero P, Taverna D.

PLoS One. 2014 Jan 6;9(1):e84859. doi: 10.1371/journal.pone.0084859. eCollection 2014.

12.

p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.

Tornillo G, Elia AR, Castellano I, Spadaro M, Bernabei P, Bisaro B, Camacho-Leal Mdel P, Pincini A, Provero P, Sapino A, Turco E, Defilippi P, Cabodi S.

Stem Cells. 2013 Jul;31(7):1422-33. doi: 10.1002/stem.1403.

13.

Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.

Todorovic M, Mesiano G, Gammaitoni L, Leuci V, Giraudo Diego L, Cammarata C, Jordaney N, Carnevale-Schianca F, Gallo S, Fagioli F, Piacibello W, Elia AR, Pignochino Y, Dell'aglio C, Grignani G, Cignetti A, Aglietta M, Sangiolo D.

J Immunother. 2012 Sep;35(7):579-86.

PMID:
22892454
14.

Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndrome.

Boita M, Rolla G, Mallone R, Martinuzzi E, Heffler E, Circosta P, Elia AR, Cignetti A, Caillat-Zucman S, de Menthon M, Guida G.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S57-61. Epub 2012 May 14.

PMID:
22640649
15.

T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.

Circosta P, Granziero L, Follenzi A, Vigna E, Stella S, Vallario A, Elia AR, Gammaitoni L, Vitaggio K, Orso F, Geuna M, Sangiolo D, Todorovic M, Giachino C, Cignetti A.

Hum Gene Ther. 2009 Dec;20(12):1576-88. doi: 10.1089/hum.2009.117.

PMID:
19678763
16.

Activin A induces Langerhans cell differentiation in vitro and in human skin explants.

Musso T, Scutera S, Vermi W, Daniele R, Fornaro M, Castagnoli C, Alotto D, Ravanini M, Cambieri I, Salogni L, Elia AR, Giovarelli M, Facchetti F, Girolomoni G, Sozzani S.

PLoS One. 2008 Sep 24;3(9):e3271. doi: 10.1371/journal.pone.0003271.

17.

Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile.

Elia AR, Cappello P, Puppo M, Fraone T, Vanni C, Eva A, Musso T, Novelli F, Varesio L, Giovarelli M.

J Leukoc Biol. 2008 Dec;84(6):1472-82. doi: 10.1189/jlb.0208082. Epub 2008 Aug 25.

PMID:
18725395
18.

Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression.

Ricciardi A, Elia AR, Cappello P, Puppo M, Vanni C, Fardin P, Eva A, Munroe D, Wu X, Giovarelli M, Varesio L.

Mol Cancer Res. 2008 Feb;6(2):175-85. doi: 10.1158/1541-7786.MCR-07-0391.

19.

Production and function of activin A in human dendritic cells.

Scutera S, Riboldi E, Daniele R, Elia AR, Fraone T, Castagnoli C, Giovarelli M, Musso T, Sozzani S.

Eur Cytokine Netw. 2008 Mar;19(1):60-8. doi: 10.1684/ecn.2008.0121. Epub 2008 Feb 26.

20.

CC-chemokine ligand 16 induces a novel maturation program in human immature monocyte-derived dendritic cells.

Cappello P, Fraone T, Barberis L, Costa C, Hirsch E, Elia AR, Caorsi C, Musso T, Novelli F, Giovarelli M.

J Immunol. 2006 Nov 1;177(9):6143-51.

Supplemental Content

Support Center